Influences on cognition by immunosuppression and immunomodulation in multiple sclerosis (Journal of Neurology (2007) 254, (SUPPL. 2) (69-72) DOI: 10.1007/s00415-007-2016-3);Influences on cognition by immunosuppression and immunomodulation in multiple sclerosis

Journal of Neurology

Volumn 254, Issue 2 SUPPL., 2007, Pages 309-

  Tumani, Hayrettin ^a   Uttner, Ingo ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Cognition; Corticosteroids; Immunomodulation; Immunosuppression; Multiple sclerosis

Indexed keywords

BETA1A INTERFERON; CORTICOSTEROID; CORTISONE; GLATIRAMER; INTERFERON BETA SERINE; METHYLPREDNISOLONE; PLACEBO;

ARTICLE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFECT; DRUG MEGADOSE; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; MEMORY DISORDER; MULTIPLE SCLEROSIS; NEUROPROTECTION; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME; WORKING MEMORY;

COGNITION DISORDERS; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-BETA; MULTIPLE SCLEROSIS;

EID: 34248531592     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-008-0901-z     Document Type: Erratum

References (36)

1. Arndt M, Kunert HJ, Sass H, Norra C (2004) Cognitive impairment after accidental high-dose corticosteroid therapy. Nervenarzt 75:904-907
2. Barak Y, Achiron A (2002) Effect of interferon-beta-1b on cognitive functions in multiple sclerosis. Eur Neurol 47:11-14
3. Beckwith BE, Petros TV, Scaglione C, Nelson J (1986) Dose-dependent effects of hydrocortisone on memory in human males. Physiol Behav 36:283-286
4. Born J, Kern W, Fehm-Wolfsdorf G, Fehm HL (1987) Cortisol effects on attentional processes in man as indicated by event-related potentials. Psychophysiology 24:286-292
5. Brunner R, Schaefer D, Hess K, Parzer P, Resch F, Schwab S (2005) Effect of corticosteroids on short-term and long-term memory. Neurology 64:335-337
6. Calabrese P (2006) Neuropsychology of multiple sclerosis - an overview. J Neurol 253(Suppl 1):I10-I15
7. Cohen JA, Cutter GR, Fischer JS et al. (2002) Benefit of interferon beta-1a on MSFC progression in secondary progressive MS. Neurology 59:679-687
8. DeQuervain DJ, Roozendaal B, McGaugh JL (1998) Stress and glucocorticoids impair retrieval of long-term spatial memory. Nature 394:787-790
9. DeQuervain DJ, Roozendaal B, Nitsch RM, McGaugh JL, Hock C (2000) Acute cortisone administration impairs retrieval of long-term declarative memory in humans. Nat Neurosci 3:313-314
10. DeSousa EA, Albert RH, Kalman B (2002) Cognitive impairments in multiple sclerosis: a review. Am J Alzheimers Dis Other Demen 17:23-29
11. Engel C, Greim B, Zettl UK (2005) Cognitive dysfunctions in multiple sclerosis patients. Nervenarzt 76:943-953
12. Exton MS, Baase J, Pithan V, Goebel MU, Limmroth V, Schedlowski M (2002) Neuropsychological performance and mood states following acute interferon-beta-1b administration in healthy males. Neuropsychobiology 45:199-204
13. Fischer JS, Priore RL, Jacobs LD et al. (2000) Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Ann Neurol 48:885-892
14. Foong J, Rozewicz L, Chong WK, Thompson AJ, Miller DH, Ron MA (2000) A comparison of neuropsychological deficits in primary and secondary progressive multiple sclerosis. J Neurol 247:97-101
15. Gerschlager W, Beisteiner R, Deecke L et al. (2000) Electrophysiological, neuropsychological and clinical findings in multiple sclerosis patients receiving interferon beta-1b: a 1-year follow-up. Eur Neurol 44:205-209
16. Keenan PA, Jacobson MW, Soleymani RM, Mayes MD, Stress ME, Yaldoo DT (1996) The effect on memory of chronic prednisone treatment in patients with systemic disease. Neurology 47:1396-1402
17. Kesselring J, Beer S (2005) Symptomatic therapy and neurorehabilitation in multiple sclerosis. Lancet Neurol 4:643-652
18. Kirschbaum C, Wolf OT, May M, Wippich W, Hellhammer DH (1996) Stress- and treatment-induced elevations of cortisol levels associated with impaired declarative memory in healthy adults. Life Sci 58:1475-1483
19. Lupien SJ, Gillin CJ, Hauger RL (1999) Working memory is more sensitive than declarative memory to the acute effects of corticosteroids: a dose-response study in humans. Behav Neurosci 113:420-430
20. Naber D, Sand P, Heigl B (1996) Psychopathological and neuropsychological effects of 8-days' corticosteroid treatment. A prospective study. Psychoneuroendocrinology 21:25-31
21. Newcomer JW, Craft S, Hershey T, Askins K, Bardgett ME (1994) Glucocorticoid-induced impairment in declarative memory performance in adult humans. J Neurosci 14:2047-2053
22. Oliveri RL, Sibilia G, Valentino P, Russo C, Romeo N, Quattrone A (1998) Pulsed methylprednisolone induces a reversible impairment of memory in patients with relapsing-remitting multiple sclerosis. Acta Neurol Scand 97:366-369
23. Oliveri RL, Valentino P, Russo C et al. (1998) Randomized trial comparing two different high doses of methylprednisolone in MS: a clinical and MRI study. Neurology 50:1833-1836
24. Rao SM (1995) Neuropsychology of multiple sclerosis. Curr Opin Neurol 8:216-220
25. Rieckmann P, Toyka KV; Multiple Sclerosis Therapy Consensus Group. Immunomodulatory staged therapy of multiple sclerosis. New aspects and practical applications, March 2002. Nervenarzt 2002 73:556-563
26. Roozendaal B, de Quervain DJ, Schelling G, McGaugh JL (2004) A systemically administered beta-adrenoceptor antagonist blocks corticosterone-induced impairment of contextual memory retrieval in rats. Neurobiol Learn Mem 81:150-154
27. Schmidt J, Gold R, Schonrock L, Zettl UK, Hartung HP, Toyka KV (2000) T-cell apoptosis in situ in experimental autoimmune encephalomyelitis following methylprednisolone pulse therapy. Brain 123:1431-1441
28. Selby MJ, Ling N, Williams JM, Dawson A (1998) Interferon beta 1-b in verbal memory functioning of patients with relapsing-remitting multiple sclerosis. Percept Mot Skills 86:1099-1106
29. Kappos L, Polman C, Freedman MS et al. (2005) Betaferon in newly emerging multiple sclerosis for initial treatment (BENEFIT): clinical results (Presentation at ECTRIMS, Saloniki 2005). Mult Scler 11(S1):10
30. Uttner I, Müller S, Zinser C et al. (2005) Reversible impaired memory induced by pulsed methylprednisolone in patients with MS. Neurology 64:1971-1973
31. Varney NR, Alexander B, MacIndoe JH (1984) Reversible steroid dementia in patients without steroid psychosis. Am J Psychiatry 141:369-372
32. Weinstein A, Schwid SR, Schiffer RB, McDermott MP, Giang DW, Goodman AD (2004) Neuropsychologic status in multiple sclerosis after treatment with glatiramer. Arch Neurol 61:1284
33. Wolkowitz OM, Reus VI, Weingartner H, Thompson K, Breier A, Doran A, Rubinow D, Pickar D (1990) Cognitive effects of corticosteroids. Am J Psychiatry 147:1297-1303
34. Wolkowitz OM, Reus VI, Canick J, Levin B, Lupien S (1997) Glucocorticoid medication, memory and steroid psychosis in medical illness. Ann N Y Acad Sci 823:81-96
35. Young AH, Sahakian BJ, Robbins TW, Cowen PJ (1999) The effects of chronic administration of hydrocortisone on cognitive function in normal male volunteers. Psychopharmacology (Berl) 145:260-266
36. Zivadinov R, Zorzon M, Tommasi MA, Nasuelli D, Bernardi M, Monti-Bragadin L, Cazzato G (2003) A longitudinal study of quality of life and side effects in patients with multiple sclerosis treated with interferon beta-1a. J Neurol Sci 216:113-118